Bloom, DE, Canning, D, Hu, L, Liu, Y, Mahal, A, and Yip, W (2010). The Contribution of Population Health and Demographic Change to Economic Growth in China and India. J Comp Econ, 38(1):17-33.
Bruce, M (2010). Perverse Incentives in the Chinese Health System and Assessment of the April 2009 Reform Asia Health Policy Program Working Papers, Stanford University.
Buchanan, J, Mihaylova, B, Gray, A, and White, N (2010). Cost-Effectiveness of Pre-Referral Antimalarial, Antibacterial, and Combined Rectal Formulations for Severe Febrile Illness PLoS ONE, 5(12):e14446.
Campbell, HE, Gray, AM, Harris, AL, Briggs, AH, and Taylor, MA (2010). Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK. Br J Cancer, 103(6):776-86.
Chandratheva, A, Geraghty, OC, Luengo-Fernandez, R, and Rothwell, PM (2010). ABCD2 score predicts severity rather than risk of early recurrent events after transient ischemic attack. Stroke, 41(5):851-6.
Dakin, H, Bentley, A, and Dusheiko, G (2010). Cost-Utility Analysis of Tenofovir Disoproxil Fumarate in the Treatment of Chronic Hepatitis B. Value Health, 13(8):922-33.
Dakin, H, Fidler, C, and Harper, C (2010). Mixed Treatment Comparison Meta-Analysis Evaluating the Relative Efficacy of Nucleos(t)ides for Treatment of Nucleos(t)ide-Naive Patients with Chronic Hepatitis B. Value Health, 13(8):934-45.
Dakin, H, Petrou, S, Haggard, M, Benge, S, and Williamson, I (2010). Mapping analyses to estimate health utilities based on responses to the OM8-30 Otitis Media Questionnaire. Qual Life Res, 19(1):65-80.
Eddama, O, Petrou, S, Norrie, J, McLennan, G, Mackenzie, F, and Norman, JE (2010). STudy of Progesterone for the Prevention of Preterm birth In Twins (STOPPIT): Findings from a cost-effectiveness analysis International Journal of Technology Assessment in Health Care, 26(2):141-148.
Fenn, P, Gray, A, Rickman, N, Vencappa,, Rivero-Arias, O, and Lotti, E (2010). Enterprise liability, risk pooling and diagnostic care Journal of Public Administration, Research and Theory, 20:i225-i242.
Gray, AM (2010). Diabetes: costs and cost-effectiveness (editorial) Diabetic Medicine(27):971-972.
Gray, AM and Papanicolas, IN (2010). Impact of symptoms on quality of life before and after diagnosis of coeliac disease: results from a UK population survey. BMC Health Serv Res, 10:105.
Koton, S, Luengo-Fernandez, R, Mehta, Z, and Rothwell, PM (2010). Independent Validation of the Prolonged Length of Stay Score. Neuroepidemiology, 35(4):263-266.
Luengo-Fernandez, R, Leal, J, and Gray, A (2010). Dementia 2010: The prevalence, economic cost and research funding compared with other major diseases Booklet, Alzheimer's Research Trust.
Mihaylova, B, Briggs, A, O'Hagan, A, and Thompson, SG (2010). Review of statistical methods for analysing healthcare resources and costs. Health Economics, Epub 2010, 27 Aug.
Mihaylova, B, Pitman, R, Tincello, D, van der Vaart, H, Tunn, R, Timlin, L, Quail, D, Johns, A, and Sculpher, M (2010). Cost-effectiveness of duloxetine: the Stress Urinary Incontinence Treatment (SUIT) study. Value Health, 13(5):565-72.
Papiernik, E, Zeitlin, J, Delmas, D, Blondel, B, Kunzel, W, Cuttini, M, Weber, T, Petrou, S, Gortner, L, Kollee, L, and Draper, ES (2010). Differences in outcome between twins and singletons born very preterm: results from a population-based European cohort. Hum Reprod, 25(4):1035-43.
Petrou, S (2010). A stepped care programme for depressive or anxiety disorders offers good value for money. Evidence Based Mental Health, 13(3):87.
Petrou, S and Kupek, E (2010). Poverty and childhood undernutrition in developing countries: a multi-national cohort study. Soc Sci Med, 71(7):1366-73.
Petrou, S, Dakin, H, Abangma, G, Benge, S, and Williamson, I (2010). Cost-utility analysis of topical intranasal steroids for otitis media with effusion based on evidence from the GNOME trial. Value Health, 13(5):543-51.